GENERAL SANTOS DOCTORS’ MEDICAL SCHOOL FOUNDATION INC.

NCM: 118-n RLE EXPOSURE

Area: ICU Inclusive Dates:November 13, 2022

Patient: Patient: ANB Attending Physician:M Students Name: Mary Grace S. Agata

Age and Sex: 76 years old,Male Year and Section: BSN4-B

Chief Complaints: Shortness of Breath

DRUGSTUDY

DRUG NAME CLASSIFICATION MECHANISM OF DOSAGE INDICATION ADVERSE EFFECT NURSING

ACTION RESPONSIBILITY
 Take the drug
Brand Name: Antiulcerant; Rebamipide is a 100 mg PO BID  Treatment for GI: after meals.
Antacids mucosal protective peptic ulcer  Monitor vital
Remapride agent and is disease  Nausea
signs (e.g BP,
postulated to Temperature,
Generic Name:  Prevention of  Vomiting
increase gastric RR, PR)
blood flow, NSAID’s induced
Rebamipide  Abdominal pain
prostaglandin gastropathy  Instruct the
biosynthesis and Constipation patients to report
decrease free any rash
oxygen radicals. SKIN:
 Observe for any
Rash abdominal
distention
  Monitor Intake
and Output

References:

● Nursing Drug Handbook (2021), 763-765. Wolters Kluwer